Purpose of the Test
- Identifying genetic mutations driving tumor growth.
- Assisting oncologists in selecting the most appropriate targeted therapy.
- Determining eligibility for global clinical trials.
Unlock personalized cancer care with advanced NGS technology that identifies specific genetic mutations in solid tumors, enabling your oncologists to match you with the most effective targeted therapies and clinical trials.
Scientific name: Comprehensive Genomic Profiling for Solid Tumors (NGS)
An advanced diagnostic test using Next-Generation Sequencing to analyze hundreds of genes in solid tumors, identifying mutations and rearrangements to guide precision medicine and personalized targeted therapy selection.